# Clinical trials recruiting in Michigan: 2,261 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 2,261 trials recruiting or not yet recruiting with a site in Michigan, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Michigan: 2,261 rows for $102.61, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 39 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/michigan

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 2,261
- Recruiting or not yet: 2,261
- Read on: November 19, 2026

## Trials

The 25 newest of 2,261, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946679 | Leveraging Telemedicine to Improve Guideline-Directed Medical Therapy Use and Outcomes Among Rural Patients With Heart Failure | University of Michigan | Not applicable | Not yet recruiting | Heart Failure, Heart Failure Hospitalization | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946679) |
| November 17, 2026 | NCT07942935 | Novel Dietary Interventions in Functional Dyspepsia | University of Michigan | Not applicable | Not yet recruiting | Functional Dyspepsia | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942935) |
| November 17, 2026 | NCT07942246 | Healing and Improving Postnatal Nights Through Sleep (HIPNoS) | Henry Ford Health System | Not applicable | Not yet recruiting | Insomnia, Depression | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942246) |
| November 16, 2026 | NCT07940387 | IV Lidocaine in Ortho Trauma Patients | Wayne State University | Phase 1 | Recruiting | Orthopedic Fractures | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940387) |
| November 16, 2026 | NCT07937696 | A Vaccine (Nous-209) for the Reduction of Colorectal Lesion Size in Patients With Lynch Syndrome | National Cancer Institute (NCI) | Phase 2 | Not yet recruiting | Colorectal Carcinoma, EPCAM Lynch Syndrome, Lynch Syndrome, MLH1 Lynch Syndrome, MSH2 Lynch Syndrome, MSH6 Lynch... | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937696) |
| November 12, 2026 | NCT07932730 | Disulfiram for Preventing Treatment Complications in Patients Undergoing CAR T-cell Therapy for Relapsed or Refractory Diffuse Large B-cell... | University of Michigan Rogel Cancer Center | Phase 1/2 | Not yet recruiting | Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932730) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 10, 2026 | NCT07928154 | MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment | Barbara Ann Karmanos Cancer Institute | Not applicable | Not yet recruiting | Breast Cancer, Gastrointestinal Cancer, Lung Cancer (Diagnosis), Prostate Cancer (Diagnosis), Head and Neck Cancer... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928154) |
| November 9, 2026 | NCT07926880 | Letter-Writing Add-On to Brief Motivational Intervention for Alcohol Use | Wayne State University | Not applicable | Recruiting | Heavy Drinking, Alcohol Drinking | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926880) |
| November 9, 2026 | NCT07924839 | PM2.5 Exposure, Obesity, and Cardiovascular Health | Michigan State University | Not applicable | Recruiting | Cardiovascular (CV) Risk | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924839) |
| November 6, 2026 | NCT07923734 | Study of Electrocardiogram (ECG) Safety of Sezaby in Neonatal Seizures | Sun Pharma Advanced Research Company Limited | Phase 4 | Not yet recruiting | Neonatal Seizure | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923734) |
| November 6, 2026 | NCT07923591 | Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923591) |
| November 6, 2026 | NCT07923526 | An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2/3 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923526) |
| November 6, 2026 | NCT07922772 | Days-Off Versus Daily Initial Peritoneal Dialysis Prescription | University of Michigan | Not applicable | Not yet recruiting | Kidney Failure | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922772) |
| November 5, 2026 | NCT07919678 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) | Pfizer | Phase 3 | Recruiting | Obesity, Overweight, Osteoarthritis of the Knee | 656 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919678) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 4, 2026 | NCT07914816 | Phase 2 Evaluation of Recombinant Human Platelet-Derived Growth Factor-BB (rhPDGF-BB) Injection for the Treatment of Infraorbital Hollowing | Lynch Regenerative Medicine | Phase 2 | Not yet recruiting | Infra-orbital Hollows, Skin Quality Improvement | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914816) |
| November 3, 2026 | NCT07912034 | EHR Integrated Remote Patient Monitoring to Reduce Readmission for Patients With Bladder Cancer Undergoing Cystectomy | University of Michigan Rogel Cancer Center | Not applicable | Recruiting | Bladder Carcinoma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912034) |
| November 2, 2026 | NCT07910552 | The Immunobiological Mechanisms of Depression in Perimenopause | Van Andel Research Institute | Observational | Recruiting | Perimenopause, Major Depressive Episode (MDE) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910552) |
| November 2, 2026 | NCT07909005 | Long Term Safety Study in Patients With HLH/MAS in Still's Disease Exposed to Gamifant. | Swedish Orphan Biovitrum | Observational | Not yet recruiting | Hemophagocytic Lymphohistiocytosis (HLH), Macrophage Activation Syndrome (MAS), Still Disease | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909005) |
| October 29, 2026 | NCT07903974 | Multimodal Intervention for Individuals With Posttraumatic Stress Disorder (PTSD) and Hazardous Alcohol Use | University of Michigan | Not applicable | Not yet recruiting | Post Traumatic Stress Disorder PTSD, Hazardous Alcohol Use | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903974) |
| October 29, 2026 | NCT07903415 | A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors. | Pfizer | Phase 1 | Recruiting | Pancreatic Ductal Adenocarcinoma, Esophageal Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC), Gastric Carcinoma... | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903415) |
| October 29, 2026 | NCT07903311 | Iron Repletion in Cystic Fibrosis | University of Michigan | Phase 4 | Not yet recruiting | Cystic Fibrosis, Iron Deficiencies, Iron Deficiency Diseases | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903311) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| University of Michigan | Ann Arbor | 399 |
| Henry Ford Hospital | Detroit | 146 |
| Karmanos Cancer Institute | Detroit | 102 |
| University of Michigan Rogel Cancer Center | Ann Arbor | 91 |
| Trinity Health Saint Mary Mercy Livonia Hospital | Livonia | 87 |
| Trinity Health IHA Medical Group Hematology Oncology - Brighton | Brighton | 84 |
| Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital | Chelsea | 84 |
| Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus | Ypsilanti | 83 |
| Trinity Health IHA Medical Group Hematology Oncology - Canton | Canton | 82 |
| Henry Ford Health System | Detroit | 82 |
| Trinity Health Saint Joseph Mercy Oakland Hospital | Pontiac | 79 |
| Bronson Methodist Hospital | Kalamazoo | 78 |
| West Michigan Cancer Center | Kalamazoo | 70 |
| Munson Medical Center | Traverse City | 69 |
| Genesys Hurley Cancer Institute | Flint | 69 |
| University of Michigan Health - Sparrow Lansing | Lansing | 68 |
| Trinity Health Saint Joseph Mercy Hospital Ann Arbor | Ann Arbor | 68 |
| Trinity Health Grand Rapids Hospital | Grand Rapids | 65 |
| Corewell Health Grand Rapids Hospitals - Butterworth Hospital | Grand Rapids | 65 |
| University of Michigan Health - West | Wyoming | 64 |
| Hurley Medical Center | Flint | 63 |
| Cancer Hematology Centers - Flint | Flint | 62 |
| Genesee Hematology Oncology PC | Flint | 62 |
| Trinity Health Muskegon Hospital | Muskegon | 61 |
| Henry Ford Health | Detroit | 59 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 10 |
| Phase 1 | 214 |
| Phase 1/2 | 189 |
| Phase 2 | 409 |
| Phase 2/3 | 68 |
| Phase 3 | 569 |
| Phase 4 | 66 |
| Not applicable | 448 |
| Observational | 288 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 117 |
| Neoplasms | 84 |
| Breast Neoplasms | 83 |
| Colorectal Neoplasms | 78 |
| Prostatic Neoplasms | 62 |
| Lung Neoplasms | 55 |
| Neoplasm Metastasis | 55 |
| Ovarian Neoplasms | 51 |
| Endometrial Neoplasms | 51 |
| Pancreatic Neoplasms | 43 |
| Squamous Cell Carcinoma of Head and Neck | 42 |
| Stomach Neoplasms | 41 |
| Heart Failure | 39 |
| Obesity | 38 |
| Recurrence | 35 |
| Melanoma | 33 |
| Carcinoma, Renal Cell | 32 |
| Multiple Myeloma | 32 |
| Triple Negative Breast Neoplasms | 31 |
| Cardiovascular Diseases | 31 |
| Diabetes Mellitus, Type 2 | 31 |
| Urinary Bladder Neoplasms | 30 |
| Small Cell Lung Carcinoma | 28 |
| Pulmonary Disease, Chronic Obstructive | 25 |
| Hematologic Neoplasms | 25 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Michigan | 162 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 69 |
| National Cancer Institute (NCI) | 65 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 56 |
| University of Michigan Rogel Cancer Center | 48 |
| Henry Ford Health System | 46 |
| VA Office of Research and Development | 37 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 35 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 33 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 33 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 29 |
| SWOG Cancer Research Network | 28 |
| Wayne State University | 26 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 26 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 26 |
| Children's Oncology Group | 26 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 24 |
| Michigan State University | 22 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 22 |
| Alliance for Clinical Trials in Oncology | 22 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 20 |
| NRG Oncology | 19 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 19 |
| Barbara Ann Karmanos Cancer Institute | 19 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 18 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Michigan

- [Maternity centers in Michigan, United States](https://specstream.ai/data/businesses/maternity-centers/michigan-united-states)
- [Korean restaurants in Michigan, United States](https://specstream.ai/data/businesses/korean-restaurants/michigan-united-states)
- [Industrial equipment manufacturers in Michigan, United States](https://specstream.ai/data/businesses/industrial-equipment-manufacturers/michigan-united-states)
- [Health food restaurants in Michigan, United States](https://specstream.ai/data/businesses/health-food-restaurants/michigan-united-states)
- [Financial services firms in Michigan, United States](https://specstream.ai/data/businesses/financial-services-firms/michigan-united-states)
- [Emergency departments in Michigan, United States](https://specstream.ai/data/businesses/emergency-departments/michigan-united-states)
